XML 13 R2.htm IDEA: XBRL DOCUMENT v3.8.0.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Mar. 31, 2018
Dec. 31, 2017
Current assets:    
Cash and cash equivalents $ 62,619 $ 64,928
Accounts receivable, net 38,689 31,625
Inventory 52,118 49,212
Prepaid expenses and other current assets 9,795 7,609
Total current assets 163,221 153,374
Property and equipment, net 59,458 60,262
Field equipment, net 23,446 24,264
Deferred cost of revenues 31,568 31,410
Intangible assets, net 7,154 7,660
Goodwill 42,748 42,748
Other assets 6,360 5,911
Total assets 333,955 325,629
Current liabilities:    
Accounts payable 15,443 14,785
Accrued expenses 26,193 27,985
Current portion of long-term debt 105 101
Other current liabilities 4,716 4,559
Total current liabilities 46,457 47,430
Deferred revenues 47,205 46,874
Long-term debt 522 520
Other long-term liabilities 18,286 17,824
Total liabilities 112,470 112,648
Commitments and contingencies (Note 10)
Noncontrolling interests subject to put provisions (171) (165)
Stockholders’ equity:    
Undesignated preferred stock: par value $0.001 per share, 5,000,000 shares authorized; no shares issued and outstanding as of March 31, 2018 and December 31, 2017 0 0
Common stock: par value $0.001 per share, 100,000,000 shares authorized; 67,561,597 and 67,341,819 shares issued as of March 31, 2018 and December 31, 2017, respectively 67 67
Additional paid-in capital 660,769 657,640
Accumulated deficit (416,982) (421,593)
Accumulated other comprehensive loss (2,514) (3,673)
Treasury stock, at cost: 1,074,909 and 1,046,870 shares as of March 31, 2018 and December 31, 2017, respectively (19,957) (19,283)
Total NxStage Medical, Inc. stockholders' equity 221,383 213,158
Noncontrolling interests not subject to put provisions 273 (12)
Total stockholders' equity 221,656 213,146
Total liabilities and stockholders’ equity $ 333,955 $ 325,629